• Viewpoint
    June 29, 2026

    The post-approval phase represents one of the most complex and strategically critical stages in the life sciences product life cycle, requiring enterprises to ensure continuous safety monitoring, regulatory compliance, and real-world performance optimization. With increasing diverse…
  • Thematic Report
    May 04, 2026

    The global Clinical Research Organization (CRO) market is undergoing a transformation, shaped by rising clinical trial complexity, increasing regulatory requirements, and growing demand for faster, more efficient drug development. CROs continue to play a pivotal role…
  • Viewpoint
    April 28, 2026

    The global safety database market is at an inflection point, driven by increasing complexities in Pharmacovigilance (PV) operations, growing regulatory expectations, and rapid expansion of data sources such as real-world evidence, digital health tools, and patient-generated…
  • Roundtable
    April 16, 2026

    Following our GBS Operating Model FutureCast workshop, Everest Group is convening a select group of GBS leaders for an interactive working session on Thursday, May 07, to pressure test emerging perspectives on reimagining the operating model in the age of agentic AI.  …
  • Roundtable
    March 31, 2026

    Following our GBS Operating Model FutureCast workshop, Everest Group is convening a select group of GBS leaders for an interactive working session on Tuesday, April 14, to pressure test emerging perspectives on reimagining the operating model in the age of agentic AI.  …
  • Provider Compendium
    Nov. 06, 2025

    Clinical Data Management (CDM) operations have become a strategic priority for life sciences enterprises as they face growing trial complexities, expanding data volumes, and the integration of decentralized and real-world data sources. These dynamics are reshaping…
  • In 2006, I visited my first captive center in Bengaluru. At the time, the model was still in its formative years – many multinational organizations were only beginning to explore the potential of setting up their own in-house centers…
  • Blog
    Nov. 02, 2025

    The clinical outsourcing market is undergoing a transition with the emergence of specialist-focused Clinical Research Organizations (CROs). A specialist CRO concentrates its expertise in a defined area, such as a therapeutic focus, trial phase or technology, or geographic niche, rather than offering broad,…
  • PEAK Matrix®
    Aug. 19, 2025

    Clinical Data Management (CDM) is rapidly transforming as life sciences enterprises navigate increasing trial complexity, heightened regulatory scrutiny, and the expansion of decentralized and real-world data sources. CDM now plays a strategic role in enabling faster,…
  • Viewpoint
    June 03, 2025

    As life sciences enterprises navigate the clinical development’s growing complexity due to advanced therapies, increased data volumes, and the need for operational agility, outsourcing models are evolving in response. Sponsors now seek flexible, cost-efficient, and expertise-driven…
  • Viewpoint
    June 02, 2025

    The pharmaceutical industry is significantly transforming, driven by escalating R&D costs, rising competition, and a rapidly evolving global regulatory landscape. In this dynamic environment, regulatory affairs have emerged from their traditional compliance-focused roles to become strategic…
  • Briefings
    May 14, 2025

    Everest Group hosted its exclusive launch event for its new Advanced SciTech Service. This program is designed to help you navigate the complex landscape of emerging science and technology, enabling you to integrate cutting-edge innovations effectively…
  • Viewpoint
    May 07, 2025

    Increasing trial complexity, growing data volumes, and the rise of decentralized and real-world data sources are fundamentally transforming the clinical trial landscape. Traditional Clinical Data Management (CDM) processes are largely manual and rely on siloed data…
  • Blog
    April 01, 2025

    Clinical trials are becoming more complex, diverse, and data-intensive than ever before. With decentralized trials, real-world evidence, and multi-source data streams reshaping the research landscape, effectively managing clinical data is no longer just an operational necessity,…
  • Conference
    Dec. 03, 2024

    Everest Group hosted its exclusive launch event for its new Advanced SciTech Service. This program is designed to help you navigate the complex landscape of emerging science and technology, enabling you to integrate cutting-edge innovations effectively…
  • Conference
    May 30, 2024

    Everest Group attended nasscom GCC Conclave 2024 and returned as a Strategic Partner for the event. During the event, Everest Group hosted the roundtable: Borderless Aspirations and Beyond: GCC Leadership and Organizational Evolution Dynamics. In this…
  • Conference
    April 18, 2024

    Everest Group hosted an invitation-only happy hour event in DFW. The evening was an opportunity to network with industry peers in the DFW area. Clients caught up, exchanged ideas, and made new acquaintances, right here in…
  • Webinar
    March 07, 2024

    Last year, the outsourcing industry faced a noticeable slowdown in demand. Now, with nudges at a potential recovery in the latter part of 2024, enterprises in the APAC region should proactively prepare for the possibility of…
  • Thematic Report
    March 07, 2024

    Last year, the outsourcing industry faced a noticeable slowdown in demand. Now, with nudges at a potential recovery in the latter part of 2024, enterprises in the APAC region should proactively prepare for the possibility of…
  • Deciding betweenServiceNow’s dedicated and shared instances can be challenging for organizations. By comparing the options against seven key parameters ranging from organizational size and business process complexity to the cost of ownership and customization options, enterprises…

Items per page